Page last updated: 2024-08-21

arsenic trioxide and Carcinoma, Ehrlich Tumor

arsenic trioxide has been researched along with Carcinoma, Ehrlich Tumor in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ibrahim, WM; Mansour, MA; Salama, AF; Shalaan, ES	1

Other Studies

1 other study(ies) available for arsenic trioxide and Carcinoma, Ehrlich Tumor

Article	Year
Combination of arsenic trioxide and cisplatin synergistically inhibits both hexokinase activity and viability of Ehrlich ascites carcinoma cells. Journal of biochemical and molecular toxicology, 2019, Volume: 33, Issue:8 Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Cell Survival; Cisplatin; Drug Synergism; Female; Hexokinase; Mice; Mice, Inbred BALB C; Oxidative Stress	2019

Article

Year

Combination of arsenic trioxide and cisplatin synergistically inhibits both hexokinase activity and viability of Ehrlich ascites carcinoma cells.

Journal of biochemical and molecular toxicology, 2019, Volume: 33, Issue:8

Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Cell Survival; Cisplatin; Drug Synergism; Female; Hexokinase; Mice; Mice, Inbred BALB C; Oxidative Stress

2019